The Manufacturers Life Insurance Company Has $589,000 Stock Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

The Manufacturers Life Insurance Company reduced its stake in LifeStance Health Group, Inc. (NASDAQ:LFST) by 2.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 79,946 shares of the company’s stock after selling 1,795 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in LifeStance Health Group were worth $589,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. increased its position in LifeStance Health Group by 124.4% during the 4th quarter. Blue Trust Inc. now owns 3,828 shares of the company’s stock valued at $27,000 after purchasing an additional 2,122 shares during the period. R Squared Ltd acquired a new stake in LifeStance Health Group during the 4th quarter valued at approximately $80,000. Cibc World Markets Corp acquired a new stake in LifeStance Health Group during the 4th quarter valued at approximately $96,000. Forum Financial Management LP acquired a new stake in LifeStance Health Group during the 4th quarter valued at approximately $110,000. Finally, Handelsbanken Fonder AB acquired a new stake in LifeStance Health Group during the 4th quarter valued at approximately $128,000. 85.50% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.20% of the company’s stock.

LifeStance Health Group Price Performance

LifeStance Health Group stock opened at $5.84 on Friday. The stock has a market capitalization of $2.27 billion, a price-to-earnings ratio of -22.46 and a beta of 1.30. LifeStance Health Group, Inc. has a 52-week low of $4.64 and a 52-week high of $8.61. The stock’s 50 day moving average price is $6.53 and its two-hundred day moving average price is $7.21. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. William Blair reissued an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group assumed coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a “buy” rating and a $8.00 target price for the company. Finally, KeyCorp assumed coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They set an “overweight” rating and a $9.00 target price for the company. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average target price of $8.30.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.